Takinib | Takinib : Inhibitor of MAP3K7
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Control Compounds
Vendors

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
MAP3K7
  • IC50:5.46 nM
  • Kd:200 nM
  • IC50:9.5 nM
  • EC50:2 µM
Inhibitor
up to 5 µM

Selectivity

In Vitro Selectivity Assessment
IRAK4

Gene ID: Q9NWZ3

Organism: Homo sapiens

Family: TKL Ser/Thr protein kinase family

Potency: IC50 - 120 nM

Selectivity Assessment Description:
Screened at 10 µM against 140 kinases, Dundee Selectivity Profiling. Closest targets >90% of control ...

Potency
Cellular
In Vitro

MAP3K7

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1016/j.chembiol.2017.07.011

In Vivo Validations

Mouse
Dose: 50 mg/kg
Route of delivery: Intraperitoneal
Plasma half life: 0.2566 h

DOI Reference: 10.1016/j.chembiol.2017.07.011

Chemical Information

Molecular Formula C18H18N4O2
SMILEs CCCn1c(/N=C(\O)c2cccc(C(=N)O)c2)nc2ccccc21
InChI InChI=1S/C18H18N4O2/c1-2-10-22-15-9-4-3-8-14(15)20-18(22)21-17(24)13-7-5-6-12(11-13)16(19)23/h3-9,11H,2,10H2,1H3,(H2,19,23)(H,20,21,24)
Molecular weight 322.14 Da
AlogP 0.0
HBond acceptors 6
HBond donors 3
Atoms 42

References

Expert Reviews


No SERP comments found for Takinib

Probe Takinib is in the process of SERP review.

Please continue to check back for new reviews and commentary.